Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Genitourinary 1

Conditions

Prostatic Neoplasms 5Breast Neoplasms 4Ovarian Neoplasms 3Triple Negative Breast Neoplasms 2Polycystic Ovary Syndrome 2Pancreatic Neoplasms 2Overweight 2Obesity 2Multiple Myeloma 2Motor Activity 2Melanoma 2Lung Neoplasms 2Glioblastoma 2Colorectal Neoplasms 2Weight Loss 1Uveal Melanoma 1Smoking Cessation 1Quality of Life 1Postoperative Complications 1Patient Compliance 1Neoplasms 1Metabolic Syndrome 1Localized Prostate Carcinoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Insulin Resistance 1Inflammation 1Hypothalamic Neoplasms 1Healthy Diet 1Glioma 1Gastrointestinal Neoplasms 1

Interventions

Tirzepatide 9Exercise 5Counseling 4semaglutide 3Resistance Training 3Methods 3Standard of Care 2Progestins 2Nutrition Assessment 2Megestrol Acetate 2Diet Therapy 2mirabegron 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1atezolizumab 1Weights and Measures 1Walk Test 1Vitamin D 1Urine Specimen Collection 1Trehalase 1Topiramate 1Therapeutics 1Tablets 1TIC10 compound 1Surveys and Questionnaires 1Stents 1Spermine Synthase 1Specimen Handling 1Sampling Studies 1Qsymia 1Psychology, Positive 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Obesity × Diet Therapy × 1 year × Clear all
NCT03880422 2026-05-07

Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer

Roswell Park Cancer Institute

Phase NA Recruiting
50 enrolled
GenitourinaryOther

Obesity, Prostatic Neoplasms, Overweight

NCT06807775 2025-09-10

Time Restricted Feeding Model in Women With Polycystic Ovary Syndrome

Hacettepe University

Phase NA Not yet recruiting
45 enrolled
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡